Big Island Coronavirus Updates

Pfizer Seeks Approval to Vaccinate Those Aged 5-11

Play
Listen to this Article
1 minute
Loading Audio... Article will play after ad...
Playing in :00
A
A
A

Pharmaceutical company Pfizer is seeking COVID-19 vaccine authorization from the federal government to allow administration of its shots to children between the ages of 5 and 11 years old.

There are approximately 28 million children within the target age group living in the US, according to a report from the Associated Press. Inoculations for them could begin in a matter of weeks, should the Food and Drug Administration (FDA) clear the request.

A public debate on approving the shots will take place between a panel of independent experts, which serves the FDA in an advisory capacity. It is set for three weeks from today, on Thursday, Oct. 26, 2021.

Company research suggests using a lower dosage for younger populations, approximately 1/3 of the amount of vaccine now administered to adults. No serious side effects were reported in 2,268 test participants between the ages of 5-11 who received that amount of vaccine, according to the AP report.

ARTICLE CONTINUES BELOW AD
ARTICLE CONTINUES BELOW AD

The FDA has already cleared the Pfizer shot for use among children ages 12-17, and Pfizer’s is the only US-authorized vaccine cleared for use as a booster immunization to high-risk demographics.

The AP added that Moderna is currently navigating the approval process for vaccine authorization in the 12-17 age group, and is conducting voluntary testing on younger populations.

The incidence of death or hospitalization due to COVID-19 infection decreases exponentially with age. However, with most public school students in the US back to in-person instruction this fall, concerns about transmission to more vulnerable populations through children reman.

ARTICLE CONTINUES BELOW AD

Beyond that, more than 500 children have died as a result of COVID-related illness, according to the American Academy of Pediatrics.

Sponsored Content

Subscribe to our Newsletter

Stay in-the-know with daily or weekly
headlines delivered straight to your inbox.
Cancel
×

Comments

This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments